-
Presenter Profile: Imaging: Incorporating Imaging Findings into Risk Assessment and Prevention Strategies
Shea Hogan, MD, MSCS, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Friday, June 5, at 3:45 p.m. CT.
-
Presenter Profile: How Low to Go? And in Whom? New Blood Pressure Targets in Diabetes
Daniel W. Jones, MD, previews a presentation at the 2026 Scientific Sessions. Attendees in New Orleans can watch the session in-person Sunday, June 7, at 8:00 a.m. CT.
-
Authors of the Standards of Care in Diabetes—2026 will share insights on annual updates
This Saturday symposium, featuring Anne Peters, MD, Elizabeth Ann Beverly, PhD, Emily D. Szmuilowicz, MD, MS, and others, will cover chapters on diabetes technology, facilitating positive health behaviors, pharmacological approaches to glycemic management, cardiovascular disease and risk management, pregnancy, and diabetes in children and adolescents.
-
Session to provide updates on MASLD, lipoprotein biology, and CV risk
Panelists will discuss an underexplored nexus of metabolic dysfunction in diabetes on the final day of the 2026 Scientific Sessions. Scott Summers, PhD, will explore the role of ceramides in metabolic dysfunction-associated steatotic liver disease and cardiovascular risk. Other topics include cholesterol, clot lysis, and thrombosis.